The immunophenotypic diagnosis of CLL relies on the identification of CD5+CD3−CD23+CD20low light chain-restricted lymphocytes in the blood or bone marrow of affected patients. The gene discussed is TNFSF14; the disease is B-cell chronic lymphocytic leukemia.